Publications:32
Jia Fu, MD, MS
About Me
Dr. Jia Fu, received her M.D degree at Wuhan University and master of science degree at Nanjing University in China. She then completed her postdoctoral fellowship training at Icahn school of medicine at Mount Sinai, NY. Currently, she is an Assistant Professor and researcher in the Department of Medicine, Division of Nephrology at Icahn School of Medicine at Mount Sinai. Her major research interest has been in the field of exploring pathogenesis of diabetic kidney disease by utilizing molecular profiling of specific cell types in murine and human kidneys. Her lab is currently deploying cutting-edge technologies to deeply understand cell type specific response and cellular crosstalk after kidney injuries, in particular, single cell RNA-seq and spatial transcriptomes. Her research has been published in numerous peer-reviewed papers in these fields.
Language
English
Position
ASSISTANT PROFESSOR | Medicine, Nephrology
Publications
Selected Publications
- Author Correction: LILRB3 genetic variation is associated with kidney transplant failure in African American recipients (Nature Medicine, (2025), 31, 5, (1677-1687), 10.1038/s41591-025-03568-z). Zeguo Sun, Zhengzi Yi, Chengguo Wei, Wenlin Wang, Tianyuan Ren, Paolo Cravedi, Fasika Tedla, Stephen C. Ward, Evren Azeloglu, Daniel R. Schrider, Yun Li, Atlas Khan, Francesca Zanoni, Jia Fu, Sumaria Ali, Shun Liu, Deguang Liang, Tong Liu, Hong Li, Caixia Xi, Thi Ha Vy, Gohar Mosoyan, Quan Sun, Ashwani Kumar, Zhongyang Zhang, Samira Farouk, Kirk Campell, Jordi Ochando, Kyung Lee, Steve Coca, Jenny Xiang, Patricia Connolly, Lorenzo Gallon, Philip J. O’Connell, Robert Colvin, Madhav C. Menon, Girish Nadkarni, John C. He, Monica Kraft, Xuejun Jiang, Xuewu Zhang, Krzysztof Kiryluk, Aravind Cherukuri, Fadi G. Lakkis, Weiguo Zhang, Shu Hsia Chen, Peter S. Heeger, Weijia Zhang. Nature Medicine
- LILRB3 genetic variation is associated with kidney transplant failure in African American recipients. Zeguo Sun, Zhengzi Yi, Chengguo Wei, Wenlin Wang, Tianyuan Ren, Paolo Cravedi, Fasika Tedla, Stephen C. Ward, Evren Azeloglu, Daniel R. Schrider, Yun Li, Atlas Khan, Francesca Zanoni, Jia Fu, Sumaria Ali, Shun Liu, Deguang Liang, Tong Liu, Hong Li, Caixia Xi, Thi Ha Vy, Gohar Mosoyan, Quan Sun, Ashwani Kumar, Zhongyang Zhang, Samira Farouk, Kirk Campell, Jordi Ochando, Kyung Lee, Steve Coca, Jenny Xiang, Patricia Connolly, Lorenzo Gallon, Philip J. O’Connell, Robert Colvin, Madhav C. Menon, Girish Nadkarni, John C. He, Monica Kraft, Xuejun Jiang, Xuewu Zhang, Krzysztof Kiryluk, Aravind Cherukuri, Fadi G. Lakkis, Weiguo Zhang, Shu Hsia Chen, Peter S. Heeger, Weijia Zhang. Nature Medicine
- LRG1 loss effectively restrains glomerular TGF-β signaling to attenuate diabetic kidney disease. Xuan Wang, Zeguo Sun, Jia Fu, Zhengying Fang, Weijia Zhang, John C. He, Kyung Lee. Molecular Therapy